Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I

Organic & Biomolecular Chemistry
Hairuo PengAndrew D Hamilton

Abstract

A series of compounds based on the carboxyl-terminal CAAL sequence of PGGTase-I substrates was designed and synthesized. Using piperazin-2-one as a semi-rigid scaffold, we have introduced critical pharmacophores in a well-defined arrangement to mimic the CAAL sequence. High potency and exceptional selectivity were obtained for inhibition of PGGTase-I with structures such as 45 and 70. Potency of this series of GGTIs was dependent on the presence of an L-leucine residue with a free carboxyl terminus, as well as an S configuration of the 3-aryl group. The selectivity was significantly enhanced by 5-methyl substitution on the imidazole ring and fluorine substitution on the 3-aryl group. Modification of the 6-position of the piperazinone scaffold was found to be unfavorable. Compounds 44 and 69, the corresponding methyl esters of 45 and 70, were found to selectively block processing of Rap1A by PGGTase-I in whole cells with IC(50) values of 0.4 microM and 0.7 microM respectively.

References

Aug 1, 1992·Current Opinion in Cell Biology·M ChowJ E Buss
Sep 4, 1992·Journal of Medicinal Chemistry·T MatsuiK Ohmoto
Mar 18, 1994·Journal of Medicinal Chemistry·S L GrahamA A Deana
Jan 19, 1996·Journal of Medicinal Chemistry·J T HuntV Manne
Jan 1, 1996·Annual Review of Biochemistry·F L Zhang, P J Casey
Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
May 30, 1997·The Journal of Biological Chemistry·C A RowellA M Garcia
May 30, 1997·The Journal of Biological Chemistry·D B WhyteJ K Pai
Apr 23, 1999·Journal of Medicinal Chemistry·A VasudevanA D Hamilton
Mar 15, 2001·Cancer Letters·S Aznar, J C Lacal
Mar 29, 2001·The Journal of Biological Chemistry·H E HuberD C Heimbrook
Apr 21, 2001·Oncogene·I P WhiteheadC J Der
May 30, 2001·Bioorganic & Medicinal Chemistry Letters·J M BergmanC J Dinsmore
Jun 20, 2001·Bioorganic & Medicinal Chemistry Letters·T J ZahnR A Gibbs
Nov 12, 2003·The EMBO Journal·Jeffrey S TaylorLorena S Beese

❮ Previous
Next ❯

Citations

Aug 25, 2009·Current Opinion in Chemical Biology·Guillaume CharronHoward C Hang
May 29, 2013·Journal of Peptide Science : an Official Publication of the European Peptide Society·Karolina PulkaAleksandra Misicka
Dec 3, 2016·Organic & Biomolecular Chemistry·Estefanía Icelo-ÁvilaLuis D Miranda
Jan 8, 2015·Organic & Biomolecular Chemistry·Michael S PerrymanDavid J Fox
Mar 1, 2013·MedChemComm·Joshua D Ochocki, Mark D Distefano
Dec 7, 2013·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Junko Ohkanda
Jun 23, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aslamuzzaman KaziSaid M Sebti
Jun 27, 2007·Journal of Combinatorial Chemistry·Sung-Chan Lee, Seung Bum Park
Apr 5, 2013·The Journal of Organic Chemistry·Jhonny AzuajeEddy Sotelo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.